These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 8980221)

  • 1. Blood vessel formation: what is its molecular basis?
    Folkman J; D'Amore PA
    Cell; 1996 Dec; 87(7):1153-5. PubMed ID: 8980221
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2.
    Vikkula M; Boon LM; Carraway KL; Calvert JT; Diamonti AJ; Goumnerov B; Pasyk KA; Marchuk DA; Warman ML; Cantley LC; Mulliken JB; Olsen BR
    Cell; 1996 Dec; 87(7):1181-90. PubMed ID: 8980225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubes, branches, and pillars: the many ways of forming a new vasculature.
    Augustin HG
    Circ Res; 2001 Oct; 89(8):645-7. PubMed ID: 11597985
    [No Abstract]   [Full Text] [Related]  

  • 4. Vascular biology: vessel guidance.
    Gridley T
    Nature; 2007 Feb; 445(7129):722-3. PubMed ID: 17301780
    [No Abstract]   [Full Text] [Related]  

  • 5. [Function of TIE2/angiopoietin in the angiogenesis and hematopoiesis].
    Suda T
    Rinsho Ketsueki; 2000 Apr; 41(4):251-5. PubMed ID: 10846448
    [No Abstract]   [Full Text] [Related]  

  • 6. Transcriptional regulation of vascular development.
    Sato T
    Circ Res; 2001 Feb; 88(2):127-8. PubMed ID: 11157660
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling.
    Patan S
    J Neurooncol; 2000; 50(1-2):1-15. PubMed ID: 11245270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant Tie2 causing venous malformation signals through Shc.
    Morris PN; Dunmore BJ; Brindle NP
    Biochem Biophys Res Commun; 2006 Jul; 346(1):335-8. PubMed ID: 16756945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning.
    Davis S; Aldrich TH; Jones PF; Acheson A; Compton DL; Jain V; Ryan TE; Bruno J; Radziejewski C; Maisonpierre PC; Yancopoulos GD
    Cell; 1996 Dec; 87(7):1161-9. PubMed ID: 8980223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tek/Tie2 signaling: new and old partners.
    Jones N; Dumont DJ
    Cancer Metastasis Rev; 2000; 19(1-2):13-7. PubMed ID: 11191051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling.
    Eklund L; Olsen BR
    Exp Cell Res; 2006 Mar; 312(5):630-41. PubMed ID: 16225862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tie receptors: new modulators of angiogenic and lymphangiogenic responses.
    Jones N; Iljin K; Dumont DJ; Alitalo K
    Nat Rev Mol Cell Biol; 2001 Apr; 2(4):257-67. PubMed ID: 11283723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling vascular morphogenesis and maintenance.
    Hanahan D
    Science; 1997 Jul; 277(5322):48-50. PubMed ID: 9229772
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular regulation of vessel maturation.
    Jain RK
    Nat Med; 2003 Jun; 9(6):685-93. PubMed ID: 12778167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of cell death signaling to blood vessel formation.
    Tisch N; Ruiz de Almodóvar C
    Cell Mol Life Sci; 2021 Apr; 78(7):3247-3264. PubMed ID: 33783563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid controls blood vessel formation by modulating endothelial and mural cell interaction via suppression of Tie2 signaling in vascular progenitor cells.
    Suzuki Y; Komi Y; Ashino H; Yamashita J; Inoue J; Yoshiki A; Eichmann A; Amanuma H; Kojima S
    Blood; 2004 Jul; 104(1):166-9. PubMed ID: 15026310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.
    Maisonpierre PC; Suri C; Jones PF; Bartunkova S; Wiegand SJ; Radziejewski C; Compton D; McClain J; Aldrich TH; Papadopoulos N; Daly TJ; Davis S; Sato TN; Yancopoulos GD
    Science; 1997 Jul; 277(5322):55-60. PubMed ID: 9204896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of a mutant form of the receptor tyrosine kinase Tie2 causing venous malformations.
    Morris PN; Dunmore BJ; Tadros A; Marchuk DA; Darland DC; D'Amore PA; Brindle NP
    J Mol Med (Berl); 2005 Jan; 83(1):58-63. PubMed ID: 15526080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of the endothelial pathogenic mechanism of TIE2-related venous malformation.
    Du Z; Zheng J; Zhang Z; Wang Y
    J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):740-748. PubMed ID: 28818232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tie-1: A potential target for anti-angiogenesis therapy.
    Yang P; Chen N; Jia JH; Gao XJ; Li SH; Cai J; Wang Z
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):615-622. PubMed ID: 26489611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.